|
US6960579B1
(en)
|
1998-05-19 |
2005-11-01 |
Alcon Manufacturing, Ltd. |
Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
|
|
GB9902047D0
(en)
*
|
1999-01-29 |
1999-03-17 |
Cerebrus Ltd |
Chemical compounds XI
|
|
US6465467B1
(en)
|
1999-05-21 |
2002-10-15 |
Biovitrum Ab |
Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
|
|
GB9918965D0
(en)
|
1999-08-11 |
1999-10-13 |
Cerebrus Ltd |
Chemical compounds xxi
|
|
WO2001040183A1
(en)
*
|
1999-12-03 |
2001-06-07 |
Alcon Universal Ltd. |
1-aminoalkyl-1h-indoles for treating glaucoma
|
|
US6806285B1
(en)
|
2000-03-17 |
2004-10-19 |
Alcon, Inc. |
5-Hydroxyl indole derivatives for treating glaucoma
|
|
US7012090B1
(en)
|
2000-03-17 |
2006-03-14 |
Alcon, Inc. |
Pyranoindoles for treating glaucoma
|
|
WO2001070223A1
(en)
*
|
2000-03-17 |
2001-09-27 |
Alcon, Inc. |
Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma
|
|
GB0019950D0
(en)
*
|
2000-08-12 |
2000-09-27 |
Smithkline Beecham Plc |
Compounds
|
|
SE0004245D0
(sv)
|
2000-11-20 |
2000-11-20 |
Pharmacia Ab |
Novel compounds and their use
|
|
CN1227237C
(zh)
|
2000-11-20 |
2005-11-16 |
比奥维特罗姆股份公司 |
作为五羟色胺5－ht2受体拮抗剂的哌嗪基吡嗪化合物
|
|
CA2432122A1
(en)
|
2000-12-20 |
2002-08-01 |
Bristol-Myers Squibb Pharma Company |
Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
|
|
AU2002305732B2
(en)
|
2001-06-01 |
2007-02-01 |
Alcon, Inc. |
Pyranoindazoles and their use for the treatment of glaucoma
|
|
WO2002098860A1
(en)
|
2001-06-01 |
2002-12-12 |
Alcon, Inc. |
Novel fused indazoles and indoles and their use for the treatment of glaucoma
|
|
BR0210238A
(pt)
|
2001-06-01 |
2004-07-20 |
Alcon Inc |
Novos análogos de aril-amino-propano e seu uso para o tratamento de glaucoma
|
|
US6884816B2
(en)
|
2001-08-31 |
2005-04-26 |
Alcon, Inc. |
Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
|
|
TW593302B
(en)
|
2001-12-20 |
2004-06-21 |
Alcon Inc |
Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
|
|
EA008148B1
(ru)
|
2002-06-19 |
2007-04-27 |
Биовитрум Аб |
Новые соединения, их применение и получение
|
|
MXPA05002259A
(es)
*
|
2002-08-30 |
2005-07-05 |
Alcon Inc |
Compuestos de 5-croman-5-il-etilamina sustituidos y uso para el tratamiento de glaucoma.
|
|
HRP20050396A2
(en)
|
2002-11-07 |
2005-06-30 |
Akzo Nobel N.V. |
Indoles useful in the treatment of androgen-receptor related diseases
|
|
EP1581209A4
(en)
|
2002-12-13 |
2009-03-11 |
Alcon Inc |
NEW BENZOPYRAN ANALOGUE AND ITS USE FOR THE TREATMENT OF GLAUKOM
|
|
CL2004000826A1
(es)
|
2003-04-25 |
2005-03-04 |
Pfizer |
Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
|
|
GB0314967D0
(en)
*
|
2003-06-26 |
2003-07-30 |
Hoffmann La Roche |
Piperazine derivatives
|
|
WO2005053688A1
(en)
|
2003-11-26 |
2005-06-16 |
Alcon, Inc. |
Substituted furo[2,3-g] indazoles for the treatment of glaucoma
|
|
TW200520760A
(en)
|
2003-12-15 |
2005-07-01 |
Alcon Inc |
Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma
|
|
US7338972B1
(en)
|
2003-12-15 |
2008-03-04 |
Alcon, Inc. |
Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
|
|
US7129257B1
(en)
|
2003-12-15 |
2006-10-31 |
Alcon, Inc. |
Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
|
|
TW200602317A
(en)
|
2004-04-23 |
2006-01-16 |
Akzo Nobel Nv |
Novel androgens
|
|
EP2248524A3
(en)
|
2004-08-25 |
2011-03-09 |
Takeda Pharmaceutical Company Limited |
Preventives/remedies for stress urinary incontinence and method of screening the same
|
|
WO2006062839A1
(en)
|
2004-12-08 |
2006-06-15 |
Alcon, Inc. |
Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
|
|
EP1869000A1
(en)
*
|
2005-03-31 |
2007-12-26 |
Pfizer Products Incorporated |
Cyclopentapyridine and tetrahydroquinoline derivatives
|
|
CN101151249B
(zh)
*
|
2005-03-31 |
2011-04-06 |
辉瑞产品公司 |
环戊吡啶及四氢喹啉衍生物
|
|
US8158617B2
(en)
|
2006-05-16 |
2012-04-17 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound and use thereof
|
|
CN101506172A
(zh)
*
|
2006-07-14 |
2009-08-12 |
辉瑞产品公司 |
（7S）-7-[（5-氟-2-甲基-苄基）氧基]-2-[（2R）-2-甲基哌嗪-1-基]-6，7-二氢-5H-环戊烷并[b]吡啶的酒石酸盐
|
|
GB0715047D0
(en)
*
|
2007-08-02 |
2007-09-12 |
Glaxo Group Ltd |
Novel Compounds
|
|
EP2216023A4
(en)
|
2007-11-15 |
2013-03-13 |
Takeda Pharmaceutical |
CONDENSED PYRIDINE DERIVATIVE AND ITS USE
|
|
KR101062376B1
(ko)
|
2008-04-10 |
2011-09-06 |
한국화학연구원 |
신규 인돌 카르복실산 비스피리딜 카르복사마이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 조성물
|
|
JPWO2011071136A1
(ja)
|
2009-12-11 |
2013-04-22 |
アステラス製薬株式会社 |
線維筋痛症治療剤
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
US20210169850A1
(en)
*
|
2016-01-21 |
2021-06-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Indoline derivatives, compositions comprising them and uses thereof
|
|
CA3029811A1
(en)
*
|
2016-07-08 |
2018-01-11 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Indoline derivatives and method for using and producing the same
|
|
WO2018064465A1
(en)
|
2016-09-29 |
2018-04-05 |
The Regents Of The University Of California |
Compounds for increasing neural plasticity
|
|
WO2019131902A1
(ja)
|
2017-12-27 |
2019-07-04 |
武田薬品工業株式会社 |
腹圧性尿失禁および便失禁の治療薬
|
|
AU2020229779B9
(en)
|
2019-02-27 |
2025-09-18 |
The Regents Of The University Of California |
Azepino-indoles and other heterocycles for treating brain disorders
|
|
CN113840600A
(zh)
|
2019-02-27 |
2021-12-24 |
加利福尼亚大学董事会 |
用于治疗脑疾病的n-取代吲哚和其他杂环化合物
|
|
KR20230066543A
(ko)
*
|
2020-06-10 |
2023-05-16 |
델릭스 테라퓨틱스, 인크. |
이소트립타민 사이코플라스토겐 및 이의 용도
|
|
WO2023114313A1
(en)
|
2021-12-15 |
2023-06-22 |
Delix Therapeutics, Inc. |
Phenoxy and benzyloxy substituted psychoplastogens and uses thereof
|
|
CA3248170A1
(en)
*
|
2022-04-19 |
2023-10-26 |
Mindset Pharma Inc. |
Indoline derivatives used as serotonergic agents useful for the treatment of disorders associated with them
|